Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
abbvie
2
×
astrazeneca
2
×
avexis
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
genentech
indiana blog main
indiana top stories
johnson & johnson
life sciences
microbiome
2
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
What
bio
fda
news
2
×
roundup
approved
august
biotech
busy
companies
days
decisions
devices
digital
disease
drug
drugs
epidemic
fatty
frenzied
growing
known
led
legacy
liver
merck
nash
nods
opioid
past
race
regulatory
sarepta’s
seven
shkreli’s
slow
strikes
stumble
suits
tends
tokens
Language
unset
Current search:
pfizer
×
abbvie
×
astrazeneca
×
photo
×
microbiome
×
news
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More